Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Clinical trial NCT03676101 · COMPLETED

Trial details

NCT number: NCT03676101
Sponsor: Shanghai Bovax Biotechnology Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cervical Cancers Vulvar Cancer Vaginal Cancer CIN1 CIN2 CIN 3 AIS Invasive Carcinoma Mild Dysplasia of Vulva Moderate Dysplasia of Vulva Vin III VaIN1

Start date: 2018-10-10
Primary completion: 2019-08-20
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.